The Role of IL-37 as an Anti-Inflammatory Biomarker in some Iraqi Rheumatoid Arthritis Patients and Its Correlation with DAS28
DOI:
https://doi.org/10.51173/jt.v4i33.708Keywords:
Rheumatoid arthritis, Anti-CCP, IL-37, DAS28Abstract
Interleukin-37 (IL-37) is a new anti-inflammatory cytokine that inhibits immunological response and inflammation. The purpose of this study is to look into the role of IL-37 and if it correlates with disease activity in some Iraqi RA patients. The scope of the investigation comprised of 76 females with RA who are aged in the range of (45.38 ±1.23 years) and 40 individuals in the control group with age of (46.48 ± 2.02years). When compared to controls, the level of serum IL-37 was shown to be considerably elevated in RA patients. (49.16 ± 3.25pg/ml vs. 32.04 ± 2.22pg/ml; p ≤ 0.05). However, the DAS28 score results showed a non-significant difference between the mild and severe rheumatoid arthritis patients. There was a positive association, statistically significant between the DAS28 score and anti-CCP Abs, RF. A positive correlation between DAS28 and ESR. While non-significantly correlated between DAS28 and CRP, IL-37.
Downloads
References
Catrina, A. I., Svensson, C. I., Malmström, V., Schett, G., & Klareskog, L. (2017). Mechanisms leading from systemic autoimmunity to joint-specific disease in rheumatoid arthritis. Nature Reviews Rheumatology, 13(2), 79-86.
Matsui T, Kuga Y, Kaneko A. (2007) Disease Activity Score 28 (DAS28) using C-reactive protein underestimates disease activity and overestimates EULAR response criteria compared with DAS28 using erythrocyte sedimentation rate in a large observational cohort of rheumatoid arthritis patients in Japan. Ann Rheum Dis.;66(9):1221–1226. doi:10.1136/ard.2006.063834
Gavrilă, B. I., Ciofu, C., & Stoica, V. (2016). Biomarkers in rheumatoid arthritis, what is new? Journal of medicine and life, 9(2), 144.
Rao, D. A., Gurish, M. F., Marshall, J. L., Slowikowski, K., Fonseka, C. Y., Liu, Y., ... & Brenner, M. B. (2017). Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis. Nature, 542(7639), 110-114.
Wasserman, A. (2011). Diagnosis and management of rheumatoid arthritis. American family physician, 84(11), 1245-1252.
Silva-Fernandes, T., Duarte, L. C., Carvalheiro, F., Loureiro-Dias, M. C., Fonseca, C., & Gírio, F. (2015). Hydrothermal pretreatment of severallignocellulosic mixtures containing wheat straw and two hardwood residues available in Southern Europe. Bioresource Technology, 183, 213-220.
M. F. Nold, C.A.Nold-Petry, J. A. Zepp, B. E. Palmer, P. Bufler, and C. A. Dinarello. (2016) “IL-37 is a fundamental inhibitor of innate immunity,” Nature Immunology, vol. 11, no. 11, pp. 1014–1022,2010.
Boutet MA, Nerviani A, Pitzalis C (2019) IL-36, IL-37, and IL-38 cytokines in skin and joint inflammation: a comprehensive review of their therapeutic potential. International Journal of Molecular Sciences 20(6):1257
Smolen, J. S., Aletaha, D., & McInnes, I. B. (2016). Therapies for bone R. Lancet. Journal port Science Research 30173-8.
Xia, T., Zheng, X. F., Qian, B. H., Fang, H., Wang, J. J., Zhang, L. L., ... & Zhao, D. B. (2015). Plasma interleukin-37 is elevated in patients with rheumatoid arthritis: its correlation with disease activity and Th1/Th2/Th17-related cytokines. Disease markers, 2015.
Alamanos Y, Voulgari PV, Drosos AA. (2006) Rheumatoid arthritis insouthern Europe: epidemiological, clinical, radiological, and ge-netic considerations. Journal of Rheumatic Diseases; 1:33-6.
Somers, E. C., Antonsen, S., Pedersen, L., & Sørensen, H. T. (2013). Parental history of lupus and rheumatoid arthritis and risk in offspring in a nationwide cohort study: does sex matter? Annals of the rheumatic diseases, 72(4), 525-529
Jaber, H.; Jasim,W.E and Abbas, A.(2020).The Evaluation of Some Biomarkers According to Rheumatoid Factor in Early Diagnosis of Rheumatoid Arthritis from Iraqi Patients. Iraqi Journal of Science 61(9):2196-2203. DOI: 10.24996/ijs.2020.61.9.6
Ali J, Saleh B & Gorial F. (2018). Diagnostic value of serum anti-carbamylated protein antibodies in Iraqi patients with rheumatoid arthritis: a case control study. (January port Science Research). G.J.B.B. 7 (1), 15-8.
Carlens C H M, Grunewald J, Ekbom A, Eklund A, Höglund CO & Askling J. (2010). Smoking, use of moist snuff, and risk of chronic inflammatory diseases. American Journal of Respiratory and Critical Care Medicine. 181:1217–1222.
Vos, I., Van Mol, C., Trouw, L. A., Mahler, M., Bakker, J. A., Van Offel, J., ... & Huizinga, T. W. (2017). Anti-citrullinated protein antibodies in the diagnosis of rheumatoid arthritis (RA): diagnostic performance of automated anti-CCP-2 and anti-CCP-3 antibodies assays. Clinical Rheumatology Journal port Science Research, 36(7), 1487-1492.
Ingegnoli, F., Castelli, R., & Gualtierotti, R. (2013). Rheumatoid factors: clinical applications. Disease markers, 35(6), 727-734.
Quinn, M., Gough, A., Green, M., devlin, J., Hensor, E., Greenstein, A., Fraser, A. and Emery, P. 2006. Anti-CCP antibodies measured 200 at disease onset help identify seronegative rheumatoid arthritis& predictor radiological and function outcome. Rheumatol.,45(4):478–480.
Abdullah, H. N., Al-Thuwani, A. N., Nadi, M. I., & Al-Badri, K. (2012). Diagnostic value of Anti-CCP antibodies compared with Rheumatoid factor in Rheumatoid arthritis patients. Journal of university of Anbar for Pure science, 6(3), 1-6.
Ezat, S.E., Mahmood, M.R., Gorial,F.I.(2021). Diagnostic and Predictive Utility of Serum Interleukin 37 in Rheumatoid Arthritis: A Case Control study. Al-Rafidain Journal of Medical Sciences.,(1):97- 101. doi: 10.54133/ajms.v1i.39.
Yuan, Z. C., Wang, J. M., Huang, A. F., Su, L. C., Li, S. J., & Xu, W. D. (2019). Elevated expression of interleukin‐37 in patients with rheumatoid arthritis. International Journal of Rheumatic Diseases, 22(6), 1123-1129.
Xia, L., Shen, H., & Lu, J. (2015). Elevated serum and synovial fluid levels of interleukin-37 in patients with rheumatoid arthritis: Attenuated the production of inflammatory cytokines. Al-Rafidain Journal of Medical Sciences 76(2), 553–557.
Mohammad, W. J., Ibrahim, N. A., Obed, S. F. & Mohammed Sh. J.(2021). Association of TNFRII polymorphisms and IL-37 in rheumatoid arthritis Iraqi patients. Journal port Science Research, 4(1), 35-40.
Gorial, F., Ezat, S., & Mahmood, M. R. (2021). Diagnostic and Predictive Utility of Serum Interleukin-37 in Rheumatoid Arthritis: A 208 Case-Control Study. Al-Rafidain Journal of Medical Sciences (ISSN: 2789-3219), 1, 97-101.
Weidlich S, Bulau AM, Schwerd T, Althans J, Kappler R, Koletzko S.(2014) Intestinal expression of the anti-inflammatory interleukin 1 homologue IL 37 in pediatric inflammatory bowel disease. The Journal of Pediatrics.;59(2):e18 26. doi: 10.1097/MPG.0000000000000387.
Ye L, Ji L, Wen Z, Zhou Y, Hu D, Yanqun Li. (2014) IL 37 inhibits the production of inflammatory cytokines in peripheral blood mononuclear cells of patients with systemic lupus erythematosus: its correlation with disease activity. Journal of Translational Medicine. 2014;12(1):69. doi: 10.1186/1479 58761269
Xia S, Wei J, Wang J, Sun H, Zheng W, Liet Y. (2014) A requirement of dendritic cell‐derived interleukin‐27 for the tumor infiltration of regulatory T cells. Journal of Leukocyte Biology.;95(5):733 742. doi: 10.1189/jlb.0713371.
Chen B, Huang K, Ye L, Li Y, Zhang J, Zhang J. (2015) Interleukin 37 is increased in ankylosing spondylitis patients and associated with disease activity. Journal of Translational Medicine;13(1):36. doi:10.1186/s12967 015 0394 3.
Choe, J. Y., Bae, J., Lee, H., Bae, S. C., & Kim, S. K. (2013). Relation of rheumatoid factor and anti-cyclic citrullinated peptide antibody with disease activity in rheumatoid arthritis: cross-sectional study. Rheumatology internationalJournal of Translational Medicine 33(9), 2373-2379.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Sattar Brissm Hassan, Hanaa N. Abdullah, Khalied Yassen Zakair
This work is licensed under a Creative Commons Attribution 4.0 International License.
